FDA Errs On Estimates For NDIs, Claims Substantiation – CRN

FDA “grossly underestimated” firms’ costs for filing new dietary ingredient notifications and ignored their costs for substantiating claims, the Council for Responsible Nutrition says in July 25 comments.